Assyro AI

FDA Orange Book · active-ingredient family

Omeprazole magnesium

Omeprazole magnesium is approved as 2 brand and 9 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:PRILOSEC · NDA 022056

2

Brand (NDA)

9

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule, delayed release, for suspension, delayed release, tablet, delayed release

ProductApplicantApplicationTEApproved
PRILOSECRLD×2AZURITYNDA 022056Mar 20, 2008
PRILOSEC OTCRLDASTRAZENECANDA 021229Jun 20, 2003

Generic (ANDA) products (9)

ProductApplicantApplicationTEApproved
OMEPRAZOLE MAGNESIUMMARKSANS PHARMAANDA 218829Aug 07, 2025
OMEPRAZOLE MAGNESIUMAUROBINDO PHARMA LTDANDA 213201Apr 28, 2023
OMEPRAZOLE MAGNESIUMDEXCELANDA 216096May 24, 2022
OMEPRAZOLE MAGNESIUMP AND LANDA 206582Jun 01, 2020
OMEPRAZOLE MAGNESIUMHETERO LABS LTD IIIANDA 211732Mar 25, 2020
OMEPRAZOLE MAGNESIUMSPILANDA 210593Jul 20, 2018
OMEPRAZOLE MAGNESIUMAUROBINDO PHARMAANDA 206877Jun 06, 2018
OMEPRAZOLE MAGNESIUMPERRIGO R AND DANDA 204152Jul 30, 2015
OMEPRAZOLE MAGNESIUMDR REDDYS LABS LTDANDA 078878Jun 05, 2009

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Omeprazole magnesium — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.